Blood flow rate: An independent risk factor of mortality in Chinese hemodialysis patients. Issue 3 (22nd September 2021)

• Record Type: Journal Article
• Authors: Zhao, Xinju; Niu, Qingyu; Gan, Liangying; Hou, Fan Fan; Liang, Xinling; Ni, Zhaohui; Chen, Xiaonong; McCullough, Keith; Zhao, Junhui; Robinson, Bruce; Chen, Yuqing; Zuo, Li
• Is Part Of: Seminars in dialysis. Volume 35:Issue 3(2022)
• Page Start: 251
• Page End: 257
• Publication Date: 2021-09-22
• Subjects: Hemodialysis -- Periodicals; Dialysis -- Periodicals; Renal Dialysis -- Periodicals; 617.461059
• DOI: 10.1111/sdi.13023
• Languages: English
• ISSNs: 0894-0959

Abstract

Abstract: Background: Studies suggested the association between blood flow rate (BFR) and mortality might be beyond dialysis adequacy. This study aimed to explore if BFR is an independent predictor of clinical outcomes in Chinese hemodialysis (HD) patients. Methods: This study included data from patients in China Dialysis Outcomes and Practice Patterns Study (DOPPS) Phase 5. Patients with a record of BFR were included, and demographic data, comorbidities, hospitalization, and death records were collected. Associations between BFR and all‐cause mortality and hospitalization were analyzed using Cox regression models. Results: One thousand four hundred twelve (98.9%) patients were included. Most patients were with BFR < 300 ml/min. After full adjustment, each 10‐ml/min increase of BFR was associated with a 6.4% decrease in all‐cause mortality risk (HR: 0.936, 95% CI: 0.880–0.996) but not first hospitalization (HR: 0.987, 95% CI: 0.949–1.027). The impact of BFR on mortality may be more prominent in patients who were male gender, nondiabetic, albumin < 4.0 g/dl, and hemoglobin ≥ 9.0 g/dl. Conclusion: Increased BFR is independently associated with a lower risk of all‐cause mortality within the range of BFR 200–300 ml/min. And this effect is more pronounced in patients who were male gender, nondiabetic, albumin < 4.0 g/dl, and hemoglobin ≥ 9.0 g/dl.